Flerie AB (FRA:1NP1) Total Equity: €340.74 Mil (As of Mar. 2026)


FRA:1NP1 Flerie AB FRA:1NP1
27 GF Score
Price €1.81
! 1 Warning Sign
View Full Analysis

What is Flerie AB Total Equity?

Flerie AB FRA:1NP1 -9.05% 27 Total Equity is €340.74 Mil as of Mar. 2026. GuruFocus rates FRA:1NP1 with a GF Score™ of 27/100. The stock has 1 warning sign investors should review.

Flerie AB's total equity for the quarter that ended in Mar. 2026 was €340.74 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Flerie AB Total Equity Historical Data

* Premium members only.

The historical data trend for Flerie AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Flerie AB Total Equity Chart

Flerie AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 42.26 30.38 318.77 364.96 310.31

Flerie AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 360.31 374.16 356.15 310.31 340.74
FRA:1NP1
27GF Score
Flerie AB FRA:1NP1
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Flerie AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Flerie AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=312.176-1.865
=310.31

Flerie AB's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=342.019-1.281
=340.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €340.74 Mil mean?
Flerie AB (FRA:1NP1) has a Total Equity of €340.74 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Flerie AB and its competitors.
Is Flerie AB's Total Equity too high?
Flerie AB's current Total Equity is €340.74 Mil. Overall, Flerie AB has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Flerie AB's Total Equity compare to VRTX and REGN?
Flerie AB's Total Equity of €340.74 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Flerie AB and its competitors. Flerie AB's current Total Equity is €340.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Flerie AB stock overvalued right now?
Flerie AB (FRA:1NP1) has a current Total Equity of €340.74 Mil. The current Total Equity is €340.74 Mil. Flerie AB's overall GF Score™ is 27/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Flerie AB (FRA:1NP1), the current Total Equity is €340.74 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Flerie AB Business Description

Other Exchanges FLERIE:Sweden1NP1:Germany
Address Skeppsbron 16, Stockholm, SWE, 111 30
Flerie AB is a pharmaceutical company focusing on immunological diseases with great medical needs for new treatment options. The portfolio of the company includes Immuno-Oncology, metabolic diseases, and biologics development and manufacturing organizations. It operates in two segments The Product Development segment, and The Commercial Growth segment. The Product Development segment consists of early and mid-stage biotech and pharma companies advancing their products and technologies toward clinical proofof-concept and marketing approvals. The Commercial Growth segment consists of companies already selling products or services, showcasing their ability to generate increasing revenues ahead of reaching sustainable profitability.
27GF Score

Get the complete analysis for FRA:1NP1

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.81
Price